Registry for patients undergoing percutaneous coronary intervention
Official title: Prospective Registry for Identifying Long-term Prognosis in Patients Who Underwent Coronary Angiography and Percutaneous Coronary Intervention for Coronary Artery Disease
Run by Samsung Medical Center · NCT05624905 · Data updated 2026-11-12
This study is collecting information from patients with coronary artery disease who have had or will have a heart procedure to see how they do over time and what factors might affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 15000 (estimated) |
| Sponsor | Samsung Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | March 20, 2016 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | August 14, 2024 |
| Trial ID | NCT05624905 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients who have undergone or are scheduled for coronary angiography and percutaneous coronary intervention.
✕Probably not a fit
Patients who do not consent to participate in the research will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather data on patients with coronary artery disease who have undergone or are scheduled for percutaneous coronary intervention. It focuses on identifying long-term prognoses and associated risk factors in this patient population. By tracking outcomes and treatment strategies, the study seeks to contribute to the evolving field of coronary interventions and improve patient care. The research will utilize data collected from patients at Samsung Medical Center in Seoul.
Why it matters
Potential benefit: If successful, this study could enhance understanding of long-term outcomes for patients undergoing percutaneous coronary intervention, leading to improved treatment strategies.
How similar studies have gone: Previous studies have shown success in understanding risk factors and outcomes in coronary artery disease, making this approach relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention. Exclusion Criteria: * patients who did not consent to the research
Where it's running
-
Samsung Medical Center
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Joo-Yong Hahn, MD
- Email: jyhahn@skku.edu
- Phone: 82-2-3410-3419
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
Long-term P2Y12 inhibitor monotherapy and blood clotting after angioplasty
This trial will test whether specific P2Y12 drugs and reduced doses given alone keep platelet activity in a safe therapeutic range for people who completed initial dual antiplatelet therapy after PCI.
-
What affects bleeding control and how long you need to lie flat after femoral arterial sheath removal
We will see if patient and procedure factors can predict how long ICU patients need compression and bed rest after femoral arterial sheath removal to prevent bleeding and hematoma.
-
Doctors' and patients' preferences for PCI implantation devices
This questionnaire tests what patients who have had PCI and the doctors who treat them prefer between drug-eluting stents and drug-coated balloons.
-
How patients and doctors value different outcomes after coronary stent procedures
This project asks patients who had a coronary stent (PCI) and the doctors who treat them to rate how important different possible outcomes are to see if their priorities match.
-
Flozins to prevent contrast-related kidney injury after coronary angiography or PCI
This project tests whether taking a flozin (empagliflozin or dapagliflozin), short-term or long-term, lowers the chance of contrast-induced acute kidney injury in patients having coronary angiography or PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.